It’s that time of the year again! With the J. P. Morgan Healthcare Conference only a few short months away, Big4Bio’s BioWeekSF.com will be up and running on November 4, 2019! This members-only website will help you navigate the craziness of JPM Week (what we call “BioWeekSF”), held in San Francisco every January. When you […]
Spotlight: Q&A With Scott Grossman on ExL Events
/ big4bio
ExL Events, a division of Questex, develops and hosts content-driven conferences and partnered events for life sciences industry professionals and academia that cover a breadth of topics from drug and device development issues and services, to hospital networks, communications, and human resources. Their diverse event portfolio is backed by extensive market research and targeted outreach […]
An Update on Big4Bio’s LinkedIn Groups
/ big4bio
As Big3Bio rebrands to Big4Bio, the organization’s LinkedIn presence will also be reshaped. LinkedIn groups have the potential to instigate meaningful discussions among members of the community. In the past, Big3Bio has cultivated three region–specific groups, Boston, San Diego, and SFBay. But with Big3Bio rebranding to Big4Bio, we have made the decision to unify the […]
Spotlight: Big3Bio Announces Upcoming Launch of Philadelphia as a New Region of Coverage; Will Rebrand as Big4Bio
/ Tilton
– Big4Bio:Philly to Recap Life Science Developments in the Greater Philadelphia Region; To Launch During BIO International Convention in Philadelphia in June – All “Big3Bio” Regional Sites of Boston, SFBay, San Diego to Come Together Into New “Big4Bio.com” Website With Philadelphia to Be Included BigBio Communications is proud to announce the upcoming expansion and rebranding […]
Spotlight: Advance Biotech Grant Program
/ Tilton
Unlock your molecule’s potential. Apply to the US and Canada Advance Biotech Grant Program Your promising molecule requires resources and support to realize it’s potential. Our Advance Biotech Grant Program, 6th edition, is open to biotech start-up companies in US and Canada to help you accelerate to clinic faster. Apply now for a chance to win […]
Spotlight: PMWC2019 Silicon Valley
/ Tilton
USING AI TO ACCELERATE THE PROMISE OF PRECISION MEDICINE By Marie Daghlian Can the application of artificial intelligence (AI) and machine learning (ML) accelerate precision medicine and deliver on its promise? The answer is an unequivocal “yes,” but we are not there yet. There are opportunities along the entire health care value chain but there […]
California Life Sciences Industry Report Highlights Continued Strong Growth
/ Tilton
BioWeekSF will soon be here again — January 5-10, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide, BioWeekSF.com, is showcasing a series of reports, special features and more. Today’s feature is a Q&A with Sara Radcliffe, President & CEO, California Life Sciences […]
Spotlight: Biotech Companies in the “Big 3” Regions Rake in the Cash
/ Tilton
BioWeekSF will soon be here again — January 5-10, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide, BioWeekSF.com, is showcasing a series of reports and other resources focusing on financing and dealmaking. This feature is from DealForma, the biopharma database providing you […]
Event Recap: BIO Investor Forum 2018
/ Tilton
By Marie Daghlian Attendees at the BIO Investor Forum braved the cacophony of striking hotel workers’ shouts and drumbeats to meet with each other, tell their stories, seek investment and partnering opportunities, and gain insight into ongoing trends in the sector over two days in mid October in sunny San Francisco. According to the Biotechnology […]
Spotlight: What Small and Emerging Companies Need When Entering Into Dealmaking Discussions
/ Tilton
BioWeekSF will soon be here again — January 6-11, 2019 — the week of the J.P. Morgan Healthcare Conference and 20 other events and forums. In preparation, the week’s premium online guide, BioWeekSF.com, is sponsoring a series of viewpoints and more from leaders and professionals involved in life sciences/healthcare dealmaking. As Chair of Foley Hoag’s Licensing & […]
Spotlight: EPPICon’s 18th Annual Meeting
/ Tilton
EPPICon’s 18th Annual Meeting is just around the corner featuring sessions on digital health, data driven drug discovery, and personalized genomics using bioinformatics. EPPIC Global’s mission is to advance healthcare by providing entrepreneurship, mentoring and networking opportunities. Since 1998, EPPIC Global has promoted interactions at the intersection of tech and healthcare to surface innovative ideas […]
Spotlight: 3rd Annual Viral Clearance and Viral Safety Summit
/ Tilton
Charles River is excited to announce its 3rd Annual Viral Clearance and Viral Safety Summit on October 9-10, 2018 in San Francisco, CA. We have lined up speakers from the Paul Ehrlich Institute, Lysogene, Amgen, Boehringer Ingelheim and CSL Behring among other companies to bring you a comprehensive look at current industry and regulatory practices […]
Spotlight: The Elizabeth Holmes and Theranos Saga
/ Tilton
Since 2014, Big3Bio has shared the rise-and-fall coverage of Elizabeth Holmes and Theranos. With the most recent development of Holmes being indicted, we’ll keep this post updated throughout the rest of 2018. UPDATED COVERAGE 9/5/18 Theranos to Dissolve – The Wall Street Journal 8/23/18 Bad Blood Author Carreyrou On Elizabeth Holmes And Theranos – CNBC […]
Event Recap: QB3 Seminar May 15, 2018 on Why Do Diagnostic Companies Fail?
/ Tilton
Urdea Talks About Why Diagnostics Companies Fail By Marie Daghlian The classroom at QB3 on the UCSF campus was small, only sixty seats, but it was packed—all the seats were taken and at least thirty more people lined the walls and sat in the center aisle. Before introducing Mickey Urdea, health sciences incubator QB3 Executive […]
May Financial Focus: While VC Funding Continues to Flow Into SF Bay Area Biotech Companies, Early Stage Funding Slows
/ Tilton
By Marie Daghlian The San Francisco Bay Area continues to be a hotbed of company formation and financing not only in tech but also in biotech. Biotech and health-related companies raked in $1.2 billion in venture capital financing in the Q1 2018 in 32 deals. While it was less than the $1.7 billion raised in […]